GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Concord Healthcare Group Co Ltd (HKSE:02453) » Definitions » Intrinsic Value: Projected FCF

Concord Healthcare Group Co (HKSE:02453) Intrinsic Value: Projected FCF : HK$0.00 (As of Jun. 04, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Concord Healthcare Group Co Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-06-04), Concord Healthcare Group Co's Intrinsic Value: Projected FCF is HK$0.00. The stock price of Concord Healthcare Group Co is HK$6.26. Therefore, Concord Healthcare Group Co's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Concord Healthcare Group Co's Intrinsic Value: Projected FCF or its related term are showing as below:

HKSE:02453's Price-to-Projected-FCF is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.11
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Concord Healthcare Group Co Intrinsic Value: Projected FCF Historical Data

The historical data trend for Concord Healthcare Group Co's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Healthcare Group Co Intrinsic Value: Projected FCF Chart

Concord Healthcare Group Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Intrinsic Value: Projected FCF
- - - - -

Concord Healthcare Group Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Intrinsic Value: Projected FCF Get a 7-Day Free Trial - - - - -

Competitive Comparison of Concord Healthcare Group Co's Intrinsic Value: Projected FCF

For the Medical Care Facilities subindustry, Concord Healthcare Group Co's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Concord Healthcare Group Co's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Concord Healthcare Group Co's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Concord Healthcare Group Co's Price-to-Projected-FCF falls into.


;
;

Concord Healthcare Group Co Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Concord Healthcare Group Co  (HKSE:02453) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Concord Healthcare Group Co's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=6.26/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Concord Healthcare Group Co Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Concord Healthcare Group Co's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Concord Healthcare Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 7 Guanghua Road, Room 26A1-26A5, East Tower, Hanwei Building, Chaoyang, Beijing, CHN, 100020
Concord Healthcare Group Co Ltd is a healthcare service provider in China that specializes in oncology. The company caters to both cancer patients and third-party medical institutions. It operates its own medical institutions to provide comprehensive oncology healthcare services to cancer patients using its medical professionals and advanced precision radiation therapy. It also provides medical equipment, software, and related services to third-party medical institutions. The company's revenue is generated from its hospital business and its medical equipment, software, and related services segment. Substantially all of the company's revenue is generated from the PRC.
Executives
Yang Jianyu
Ascendium Group Limited
Concord Medical Services Holdings Limited
Morgancreek Investment Holdings Limited
Zhang Bi
Shanghai Medstar Financial Leasing Company Limited
China International Capital Corporation Limited
Zhong Jin Zi Ben Yun Ying You Xian Gong Si
Zhong Jin Jia Tai Er Qi Tian Jin Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo
Beijing Concord Medical Technology Co., Ltd.
Concord Hospital Management Group Limited
Tianjin Concord Medical Technology Co., Ltd.

Concord Healthcare Group Co Headlines

No Headlines